Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy CEO bought 820,826 shares at an average $0.49 ($406,149)
  2. 4 Derivatives Options or other derivatives
  3. 4/A Derivatives Options or other derivatives
  4. 4 Open-market buy CEO bought 500,000 shares at $0.66 ($330,000)
  5. 4 Gift CEO gave 10,813 shares (gift)
  6. 4 Open-market sale Medical Director sold 50,900 shares at an average $0.55 ($27,998)
  7. 4 Open-market buy Medical Director bought 230,586 shares at $0.58 ($132,587)
  8. 4 Open-market buy Vice President of Operations bought 185,748 shares at $0.59 ($109,777)
  9. 4 Open-market buy Chief Financial Officer bought 198,135 shares at $0.59 ($117,296)
  10. 4 Gift CEO gave 5,000 shares (gift)
  11. 4 Gift CEO gave 5,000 shares (gift)
  12. 4 Gift CEO gave 20,000 shares (gift)
  13. 4 Open-market buy Vice President of Operations bought 877 shares at $0.56 ($493)
  14. 4 Open-market buy Senior Vice President bought 2,500 shares at $0.64 ($1,600)
  15. 4 Open-market buy Medical Director bought 12,000 shares at $0.57 ($6,785)
  16. 4 Open-market buy CFO bought 2,000 shares at $0.56 ($1,126)
  17. 4 Open-market buy CEO bought 30,000 shares at $0.57 ($17,070)
  18. 4 Grant or award Director acquired 19,455 shares (grant or award)
  19. 4 Gift CEO gave 3,630 shares (gift)
  20. 4 Gift CEO gave 14,900 shares (gift)

Page 23 of 31 · 616 filings